Riskpilot← Back to searchSign inGet full accessLarsson Medical AB
ABActiveOrg 5590270616Ålhult HilmasgårdenMedical specialists activities · NACE 8622Est. 20151 employees
Revenue 2025
SEK 153K
-57% vs 2024
EBITDA margin
58.2%
+915% vs 2024
Equity ratio
45.4%
Financial strength
Net profit 2025
SEK 161K
+1370% vs 2024
| Revenue | SEK 153K | -57% |
| EBITDA | SEK 89K | +915% |
| Net profit | SEK 161K | +1370% |
| Total assets | SEK 487K | +12% |
| Equity | SEK 221K | +271% |
| Employees | 1 | — |
Legal name
Larsson Medical AB
Org number
5590270616
Legal form
Aktiebolag
NACE code
8622 · Medical specialists activities
Founded
18 september 2015
Share capital
SEK 50 000
Employees
1 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2025-04-30
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen
Company purpose
Aktiebolaget ska sälja specialisttjänster i öppen och sluten vård och erbjuda tjänster inom friskvård samt bedriva utbildning inom området. Aktiebolaget ska också erbjuda uthyrningsverksamhet, event och förtäring och samt handla med värdepapper och därmed förenlig verksamhet.
Address
Ålhult Hilmasgården
Email
johan@larssonmedical.se
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | 275 | 318 | 628 | 357 | 153 |
| Staff expenses | — | — | −512 | −183 | 48 |
| EBITDA | 119 | 120 | 31 | 9 | 89 |
| Depreciation & amort. | −0 | −0 | — | — | — |
| EBIT | 119 | 120 | 31 | 9 | 89 |
| Net financials | — | — | 0 | 1 | 79 |
| Profit before tax | 119 | 120 | 31 | 10 | 168 |
| Tax | −35 | −35 | −18 | −22 | −7 |
| Net profit | 84 | 85 | 13 | −13 | 161 |
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Total assets | 386 | 396 | 447 | 436 | 487 |
| Equity | 194 | 150 | 72 | 60 | 221 |
| Long-term debt | 0 | 0 | — | — | — |
| Short-term debt | 65 | 72 | 153 | 67 | 26 |
| Total debt | 65 | 72 | 153 | 67 | 26 |
EBITDA margin
58.2%
This company
15.8%
Market median
+268% vs market
20212025
Equity ratio
45.4%
This company
38.2%
Market median
+19% vs market
20212025
Return on equity
73.0%
This company
18.4%
Market median
+297% vs market
20212025
Net profit margin
105.5%
This company
8.1%
Market median
+1202% vs market
20212025
Asset turnover
0.31×
This company
1.12×
Market median
-72% vs market
20212025
Debt / equity
1.20×
This company
0.62×
Market median
-94% vs market
20212025
- Annual report 2025Filed via Bolagsverket / SCB · Period 2024-05-01 – 2025-04-30
- Annual report 2024Filed via Bolagsverket / SCB · Period 2023-05-01 – 2024-04-30
- Annual report 2023Filed via Bolagsverket / SCB · Period 2022-05-01 – 2023-04-30
- Annual report 2022Filed via Bolagsverket / SCB · Period 2021-05-01 – 2022-04-30
- Annual report 2021Filed via Bolagsverket / SCB · Period 2020-05-01 – 2021-04-30
No data on file.
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
| Deputy Board Member | 2022 | |
| Board of Directors | 2021 | |
| Former (1) | ||
| Deputy Board Member | 2021 – 2022 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of Larsson Medical AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Göte Sven-Erik Larsson | Deputy Board Member | 0 companies |
| I L Gunilla Gustavsson Larsson | Deputy Board Member | 0 companies |
| Johan Sven-Erik Larsson | Board of Directors | 0 companies |